Bryan Rea, MD
Assistant Professor of Pathology

Dr. Rea is a member of the Division of Hematopathology.

Office Location:
Hill Building, Rm. 347
3477 Euler Way
Pittsburgh, PA 15213
Contact Information:
Office Telephone: 412-578-9414
Fax: 412-647-6332


  • BS - Illinois Wesleyan University, 2009
  • MD - University of Illinois College of Medicine, 2013
  • Residency - Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, 2017
  • Fellowship - Surgical Pathology, Hospital of the University of Pennsylvania, Philadelphia, 2018
  • Fellowship - Hematopathology, UPMC, 2019

Clinical Expertise

Hematopathology, Surgical Pathology

Research Interests

Cytogenetic and molecular genetic characterization of hematopoietic neoplasms

Selected Publications

  1. Rea B, Samulski TD, Strauser H, Aikawa V, Luger S, Bagg A. Chronic lymphocytic leukemia with a t(8;14)(q24;q32): FISHing catches a (sheepish) red herring. American Journal of Hematology. 2015 Dec;90(12):1187-8.
  2. Wang SA, Tam W, Tsai A, Arber DA, Hasserjian RP, Geyer JT, George T, Czuchlewski DR, Foucar K, Rogers HJ, Hsi E, Rea B, Bagg A, Dal Cin P, Kelley T, Verstovsek S, Bueso-Ramos C, Orazi A. Targeted Next Generation Sequencing Identifies a Subset of Idiopathic Hypereosinophilic Syndrome with Features Similar to Chronic Eosinophilic Leukemia, Not Otherwise Specified. Modern Pathology. 2016 Aug;29(8):854-64.
  3. Rea B, Frank D. An uncommon manifestation of acute leukemia. Gastrointestinal Endoscopy. 2017 Jul;86(1):240-242. Epub 2016 Dec 22.
  4. Rea B, Hawkins J, Min H, Maniglia R, Talati N, Glaser L. Corynebacterium propinquum endocarditis: a confounding presentation of a rare entity. Cardiovascular Pathology. 2017 (28): 71-73.
  5. Wang SA, Hasserjian RP, Tam W, Tsai AG, Geyer JT, George TI, Foucar K, Rogers HJ, Hsi ED, Rea BA, Bagg A, Bueso-Ramos C, Arber DA, Verstovsek S, Orazi A. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified from reactive idiopathic hypereosinophilic syndrome. Haematologica. 2017 Volume 102(8):1352-1360.
  6. Margolskee E, Mikita G, Rea B, Bagg A, Zuo Z, Sun Y, Goswami M, Wang SA, Oak J, Arber DA, Allen MB, George TI, Rogers HJ, Hsi E, Hasserjian RP, Orazi A. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria. Mod Pathol. 2018 Jun;31(6):873-880.
  7. Rea B, Haun P, Emerson R, Vignali M, Farooqi M, Samimi S, Elenitsas R, Kirsch I, Bagg A. Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma. J Clin Pathol. 2018 Sep;71(9):814-820.
  8. Rea B, Masiel J, Glaser L, Alby K. Identification of Clinically Relevant Mycobacterial Species after Extended Incubation Times in the BACTEC™ MGIT™ System. American Journal of Clinical Pathology. Am J Clin Pathol. 2019 Jan 1;151(1):63-67.
  9. Wang J, Rea B, Haun P, Emerson R, Kirsch I, Bagg A. High-Throughput Sequencing of the T-cell receptor beta chain gene distinguishes two subgroups of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2019 Apr;80(4):1148-1150.e1.
  10. McMahon CM, Canaani J, Rea B, Sargent RL, Qualtieri JN, Watt CD, Morrissette JJD, Carroll M, Perl AE. Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia. Blood Adv. 2019 May 28;3(10):1581-1585.
  11. Rea B, Peel RL, Han M, Ohori NP, Aggarwal N. Intravascular Large B-cell Lymphoma Involving Multinodular Goiter and Mimicking Carcinoma. Int J Surg Pathol. Accepted 29 Jun 2019.